Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01310270 · ClinicalTrials.gov registry record · NA
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT01310270 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 180 participants.
The verdict
NCT01310270, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
The hypothesis being tested is that in patients with stable claudication and documented PAD, omega-3 supplementation for 1 month will lead to improvement in endothelial function as measured by flow-mediated, brachial artery vasodilation (FMD), as well as improvement in the vascular inflammatory profile as measured by a panel of established circulating inflammatory biomarkers.
Interventions
- DIETARY_SUPPLEMENT Pro-Omega
- DIETARY_SUPPLEMENT Omega 3 Fatty Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2011-04 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01310270
The ClinicalTrials.gov registry entry for NCT01310270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pro-Omega is the first listed.
NCT01310270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01310270 about?
NCT01310270 is a clinical study titled "The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation". The hypothesis being tested is that in patients with stable claudication and documented PAD, omega-3 supplementation for 1 month will lead to improvement in endothelial function as measured by flow-mediated, brachial artery vasodilation (FMD), as well as improvement in the vascular inflammatory prof...
What is the current status of trial NCT01310270?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2011-04. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01310270?
The interventions under investigation include: Pro-Omega (DIETARY_SUPPLEMENT), Omega 3 Fatty Acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01310270?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.